DEINOVE

ISIN: FR0010879056 | Ticker: ALDEI | LEI: 969500BEJSRFER0F2K08

Sector: Health Care – Sub-Industry: Biotechnology

Country: France

About DEINOVE

Company Description

DEINOVE is a French biotechnology company pioneering the exploration of a new domain of life, unexplored at 99.9%: the “microbial dark matter”. By revealing the metabolic potential of rare bacteria or still classified as uncultivable, it tackles a global health and economic challenge: antimicrobial resistance.

The new therapies discovered and developed by DEINOVE target superbugs (microbes that have become resistant to one or more antimicrobials) that cause life-threatening infections which are now spreading at high speed.

Year founded

2006

Served area

Worldwide

Headcount

Headquarters

Cap Sigma, ZAC Euromédecine II 1682 Rue de la Valsière, 34790 Grabels – France

Filings & Publications

Insider Trades

Capital markets information

ISIN

FR0010879056

LEI

969500BEJSRFER0F2K08

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Euronext Paris

Main Stock Exchange

View DEINOVE on stock exchange

Contact Investor Relations department

First name*

Last name*

Your email*

Your phone number

Your company

Your message

I agree to the terms of the privacy policy.*

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.